
Organovo Holdings ONVO
Quarterly report 2025-Q4
added 02-11-2026
Country |
|
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
1.46 M |
Market Cap[1] |
$ 19.4 M |
EBITDA (LTM) |
$ -13.7 M |
P/E (LTM) |
- |
P/S (LTM) |
168.58 |
EPS (LTM) |
-5.43 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 17.01 | -0.12 % | $ 179 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 118.05 | 0.44 % | $ 35.9 B | NYSE,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 20.96 | 1.26 % | $ 1.12 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 1.61 | 1.26 % | $ 2.14 M | Nasdaq Capital Market | ||
|
Castle Biosciences
CSTL
|
$ 24.81 | 0.85 % | $ 689 M | Nasdaq Global Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 183.48 | -1.03 % | $ 9.09 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Medpace Holdings
MEDP
|
$ 427.17 | -0.73 % | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.01 | -20.18 % | $ 371 M | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
NeoGenomics
NEO
|
$ 8.89 | 0.28 % | $ 1.14 B | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 17.96 | -4.16 % | $ 402 M | Nasdaq Global Select Market | ||
|
Fulgent Genetics
FLGT
|
$ 15.03 | 0.87 % | $ 454 M | Nasdaq Global Market | ||
|
Natera
NTRA
|
$ 217.47 | 5.17 % | $ 21.4 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.16 | 2.68 % | $ 20 B | NYSE | ||
|
Guardant Health
GH
|
$ 92.19 | 2.98 % | $ 11.6 B | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 6.01 | 8.09 % | $ 356 M | Nasdaq Global Select Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 123.63 | 1.9 % | $ 10.2 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 141.82 | 1.97 % | $ 22.5 B | Nasdaq Global Select Market,SPB | ||
|
Soleno Therapeutics
SLNO
|
$ 52.93 | 0.02 % | $ 2.69 B | Nasdaq Capital Market | ||
|
Senseonics Holdings
SENS
|
$ 5.38 | 7.6 % | $ 224 M | NYSE American | ||
|
Interpace Biosciences
IDXG
|
$ 2.05 | 2.09 % | $ 9.07 M | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Thermo Fisher Scientific
TMO
|
$ 472.27 | 1.18 % | $ 178 B | NYSE,SPB | ||
|
Biomerica
BMRA
|
$ 2.22 | 1.6 % | $ 5.1 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 85.47 | -0.41 % | $ 5.77 B | Nasdaq Global Select Market,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.61 | 2.11 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 257.56 | 0.16 % | $ 21.4 B | NYSE,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 59.55 | 5.03 % | $ 3.56 B | Nasdaq Global Select Market,SPB | ||
|
Celcuity
CELC
|
$ 139.94 | -1.24 % | $ 6.54 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.16 | -1.13 % | $ 1.99 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 189.52 | -0.69 % | $ 21 B | NYSE,SPB | ||
|
Waters Corporation
WAT
|
$ 348.15 | 1.58 % | $ 20.7 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.